Facebook
Linkedin
Twitter
Home
Phil’s Posts
MEMBERS ONLY
Top Trades
Virtual Portfolio Review
Webinars
BNN Money Talk
Market Charts
AI
Biotech
Perspectives
Politics
Science
Strategy
Tech
Trading Education
Contact Us
An invitation from Phil
SIGN IN
SUBSCRIBE
Privacy Policy
Search
Sign in
Welcome! Log into your account
your username
your password
Log in With Facebook
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
25.1
C
New York
Sunday, August 30, 2026
Sign In
Home
Phil’s Posts
MEMBERS ONLY
Top Trades
Virtual Portfolio Review
Webinars
BNN Money Talk
Market Charts
AI
Biotech
Perspectives
Politics
Science
Strategy
Tech
Trading Education
Contact Us
An invitation from Phil
SIGN IN
SUBSCRIBE
Privacy Policy
Home
Tags
GlaxoSmithKline
Tag:
GlaxoSmithKline
Perspectives
U.K. Medical Journal Questions Avandia License
Ilene
-
September 6, 2010
Perspectives
After Avandia: Does the FDA Have a Drug Problem?
Ilene
-
August 14, 2010
Hot Items
Something to Love about GSK
Ilene
-
June 23, 2010
Perspectives
Study Suggests HPV Vaccine Is Safe, but Doctors Wary
Ilene
-
August 19, 2009
Stay Connected
0
Fans
Like
3,912
Followers
Follow
22,900
Subscribers
Subscribe
Latest Articles
Markets
Uber Drivers Say Waymo Robotaxis Are Driving Down Their Pay
Markets
Elon Musk’s satellites are clogging up space, risking massive collision, analysis says
Markets
Iceland votes against restarting EU membership talks
Markets
3 states battling new measles outbreaks. What to know
Markets
Trump promises to ‘fill up’ SPR after US-Venezuela oil deal
Markets
Intel vs. AMD: Why the Market Share Number Is Misleading
Markets
Howard Lutnick Warns Kennedy Center Demolition Could Be ‘Eventuality’ as Board Delays Trump Naming Plan Until October
Markets
IBM quantum computer solves classically intractable problem in 15 minutes
Markets
Spider-Man: Brand New Day Closes In On Avatar 2 As Global Box Office Hits $2.33 Billion
Markets
Trump vowed to protect ‘every acre’ of U.S. lands. Days later, his administration is considering giving a piece of Yosemite to a private developer
Markets
As super El Nino strengthens, study suggests that climate change is intensifying El Ninos
Markets
Welcome to the Don’t Ask, Don’t Tell AI Economy
Load more